In tumor-induced insomnia and sleep-wakefulness cycle disorder, orexin of the central nervous system may inhibit the autophagy of tumor cells through mTOR-dependent PI3K/Akt tumor signal pathways. This evidence concerns the gene AKT1 and sleep-wake disorder.